Stay updated on GABA-A Targeting in ASD Clinical Trial
Sign up to get notified when there's something new on the GABA-A Targeting in ASD Clinical Trial page.
Latest updates to the GABA-A Targeting in ASD Clinical Trial page
- Check4 days agoChange DetectedNew screenshots show a redesigned layout and styling of the Study Details page, with no changes to core study information such as the title, status, locations, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check11 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference5%
- Check39 days agoChange DetectedVersion bumped to v3.1.0 and several safety-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) removed; previous v3.0.2 reference removed as part of the update.SummaryDifference0.6%
- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.3%
- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to drug safety and counterfeit drugs. The previous version's location details and references to autistic disorder have been removed.SummaryDifference2%
Stay in the know with updates to GABA-A Targeting in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GABA-A Targeting in ASD Clinical Trial page.